Volume 98, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Vietnam is endemic for dengue. We conducted a series of retrospective and prospective studies to characterize the epidemiology of dengue and population mobility patterns in Nha Trang city, Vietnam, with a view to rational design of trials of community-level interventions. A 10-year time series of dengue case notifications showed pronounced interannual variability, as well as spatial heterogeneity in ward-level dengue incidence (median annual coefficient of variation = 0.47). Of 451 children aged 1–10 years enrolled in a cross-sectional serosurvey, almost one-third had evidence of a past dengue virus (DENV) infection, with older children more likely to have a multitypic response indicative of past exposure to ≥ 1 serotype. All four DENV serotypes were detected in hospitalized patients during 8 months of sampling in 2015. Mobility data collected from 1,000 children and young adults via prospective travel diaries showed that, although all ages spent approximately half of their daytime hours (5:00 –9:00 ) at home, younger age groups (≤ 14 years) spent a significantly greater proportion of their time within 500 m of home than older respondents. Together these findings inform the rational design of future trials of dengue preventive interventions in this setting by identifying 1) children < 7 years as an optimal target group for a flavivirus-naive serological cohort, 2) children and young adults as the predominant patient population for a study with a clinical end point of symptomatic dengue, and 3) substantial spatial and temporal variations in DENV transmission, with a consequent requirement for a trial to be large enough and of long enough duration to overcome this heterogeneity.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

Loading full text...

Full text loading...



  1. Bhatt S, 2013. The global distribution and burden of dengue. Nature 496: 504507.
  2. Simmons CP, Farrar JJ, Nguyen vV, Wills B, , 2012. Dengue. N Engl J Med 366: 14231432.
  3. World Health Organization, 2017. Dengue and Severe Dengue–Fact Sheet Updated on April 2017. Available at: http://www.who.int/mediacentre/factsheets/fs117/en/. Accessed May 16, 2017.
  4. Stoddard ST, 2013. House-to-house human movement drives dengue virus transmission. Proc Natl Acad Sci USA 110: 994999.
  5. Wilson ME, Chen LH, , 2015. Dengue: update on epidemiology. Curr Infect Dis Rep 17: 457.
  6. Stanaway JD, 2016. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 16: 712723.
  7. Cuong HQ, Hien NT, Duong TN, Phong TV, Cam NN, Farrar J, Nam VS, Thai KT, Horby P, , 2011. Quantifying the emergence of dengue in Hanoi, Vietnam: 1998–2009. PLoS Negl Trop Dis 5: e1322.
  8. Cuong HQ, Vu NT, Cazelles B, Boni MF, Thai KT, Rabaa MA, Quang LC, Simmons CP, Huu TN, Anders KL, , 2013. Spatiotemporal dynamics of dengue epidemics, southern Vietnam. Emerg Infect Dis 19: 945953.
  9. Ministry of Health Vietnam, 2014. Guidance on Monitoring, Prevention, and Control of Dengue. Available at: http://moh.gov.vn/legaldoc/pages/operatingdocument.aspx?ItemID=393. Accessed May 30, 2017.
  10. Anders KL, Nguyet NM, Chau NV, Hung NT, Thuy TT, Lien le B, Farrar J, Wills B, Hien TT, Simmons CP, , 2011. Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg 84: 127134.
  11. Lam PK, 2013. Clinical characteristics of dengue shock syndrome in Vietnamese children: a 10-year prospective study in a single hospital. Clin Infect Dis 57: 15771586.
  12. L’Azou M, 2016. Symptomatic dengue in children in 10 Asian and Latin American countries. N Engl J Med 374: 11551166.
  13. Capeding MR, 2014. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384: 13581365.
  14. Villar L, 2015. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med 372: 113123.
  15. World Health Organization, 2016. Dengue vaccine: WHO position paper–July 2016. Wkly Epidemiol Rec 91: 349364.
  16. Quyen NTH, 2017. Chikungunya and Zika virus cases detected against a backdrop of endemic dengue transmission in Vietnam. Am J Trop Med Hyg 97: 146150.
  17. Hashimoto T, 2017. Importation of Zika virus from Vietnam to Japan, November 2016. Emerg Infect Dis 23: 12231225.
  18. Meltzer E, 2016. Zika virus disease in traveler returning from Vietnam to Israel. Emerg Infect Dis 22: 15211522.
  19. Bowman LR, Donegan S, McCall PJ, , 2016. Is dengue vector control deficient in effectiveness or evidence?: systematic review and meta-analysis. PLoS Negl Trop Dis 10: e0004551.
  20. Wolbers M, Kleinschmidt I, Simmons CP, Donnelly CA, , 2012. Considerations in the design of clinical trials to test novel entomological approaches to dengue control. PLoS Negl Trop Dis 6: e1937.
  21. Reiner RC, Jr 2016. Quantifying the epidemiological impact of vector control on dengue. PLoS Negl Trop Dis 10: e0004588.
  22. Greenland S, Thomas DC, , 1982. On the need for the rare disease assumption in case-control studies. Am J Epidemiol 116: 547553.
  23. General Statistics Office of Khanh Hoa Province, 2010. Demographic and Housing Census in Khanh Hoa province on April 1, 2009. Nha Tran City, Vietnam, General Statistics Office of Khanh Hoa Province.
  24. Bennett S, Woods T, Liyanage WM, Smith DL, , 1991. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q 44: 98106.
  25. The World Bank, 2016. Sampling with Probability Proportional to Size. Available at: http://go.worldbank.org/QM2VE8B1S0. Accessed January 20, 2015.
  26. Russell PK, Nisalak A, Sukhavachana P, Vivona S, , 1967. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 99: 285290.
  27. Thomas SJ, Nisalak A, Anderson KB, Libraty DH, Kalayanarooj S, Vaughn DW, Putnak R, Gibbons RV, Jarman R, Endy TP, , 2009. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance. Am J Trop Med Hyg 81: 825833.
  28. Hue KD, Tuan TV, Thi HT, Bich CT, Anh HH, Wills BA, Simmons CP, , 2011. Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma. J Virol Methods 177: 168173.
  29. Lavrakas P, , 2008. Encyclopedia of Survey Research Methods. Thousand Oaks, CA: SAGE Publications Ltd.
  30. Cummings DA, Irizarry RA, Huang NE, Endy TP, Nisalak A, Ungchusak K, Burke DS, , 2004. Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand. Nature 427: 344347.
  31. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, Burke DS, Hoke CH, Innis BL, Vaughn DW, , 2003. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68: 191202.
  32. Stoddard ST, 2014. Long-term and seasonal dynamics of dengue in Iquitos, Peru. PLoS Negl Trop Dis 8: e3003.
  33. Cuong HQ, 2016. Synchrony of dengue incidence in Ho Chi Minh city and Bangkok. PLoS Negl Trop Dis 10: e0005188.
  34. Walker T, 2011. The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature 476: 450453.
  35. Schmidt TL, 2017. Local introduction and heterogeneous spatial spread of dengue-suppressing Wolbachia through an urban population of Aedes aegypti. PLoS Biol 15: e2001894.
  36. Anders KL, 2017. Applying Wolbachia to eliminate dengue (AWED): study protocol for a cluster randomised controlled trial to assess the efficacy of Wolbachia-infected mosquito deployments to reduce dengue incidence in Yogyakarta, Indonesia. Trials (In Press).
  37. Lambrechts L, 2015. Assessing the epidemiological effect of Wolbachia for dengue control. Lancet Infect Dis 15: 862866.
  38. Hayes RJ, Bennett S, , 1999. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 28: 319326.
  39. Vazquez-Prokopec GM, 2013. Using GPS technology to quantify human mobility, dynamic contacts and infectious disease dynamics in a resource-poor urban environment. PLoS One 8: e58802.
  40. Reiner RC, Jr Stoddard ST, Scott TW, , 2014. Socially structured human movement shapes dengue transmission despite the diffusive effect of mosquito dispersal. Epidemics 6: 3036.
  41. Hayes RJ, Moulton LH, , 2009. Cluster Randomized Trials. London, United Kingdom: Chapman & Hall/CRC Press.
  42. Hadinegoro SR, 2015. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 373: 11951206.
  43. Ferguson NM, 2015. Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti. Sci Transl Med 7: 279ra37.
  44. ProMED-mail, 2016. Zika virus - Viet Nam: first report. ProMED-mail 5 Apr: 20160405.4138687.

Data & Media loading...

Supplementary Data

Supplemental Figure

  • Received : 07 Aug 2017
  • Accepted : 31 Oct 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error